Owner BRAINCELLS, INC.

Inventors Carter, Todd A.; Lorrain, Kym I.; Treuner, Kai; Morse, Andrew; Barlow, Carrolee

Agent Spruson & Ferguson

Pub. Number AU-A-2007249435

PCT Pub. Number WO2007/134077

Priority 60/805,436 21.06.06 US; 60/882,429 28.12.06 US; 60/746,878 09.05.06 US

Filing date 8 May 2007

Wipo publication date 22 November 2007

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/195 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/437 (2006.01)

A61K 31/4458 (2006.01) - only substituted in position 2, e.g. methylphenidate

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/538 (2006.01)

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/64 (2006.01) - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide